These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9580485)

  • 21. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage.
    Frati Munari AC; Benítez Pinto W; Raúl Ariza Andraca C; Casarrubias M
    Arch Med Res; 1998; 29(2):137-41. PubMed ID: 9650328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the safety and efficacy of acarbose in diabetes mellitus.
    Yee HS; Fong NT
    Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acarbose (glucobai) effects on lipid metabolism in patients with non-insulin dependent diabetes mellitus].
    Rosliakova LV; Roĭtman AP; Ametov AS; Dolgov VV
    Ter Arkh; 2000; 72(8):54-6. PubMed ID: 11019430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of acarbose on carbohydrate and lipid metabolism in type II diabetes with secondary failure].
    Heuer LJ; Kaufmann HH
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(2):52-8. PubMed ID: 3924553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of acarbose on familiar hypertriglyceridemias.
    Malaguarnera M; Giugno I; Panebianco MP; Pistone G
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):441-5. PubMed ID: 9726698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification in sucrose tolerance test with acarbose, guargum and their combination in patients with non-insulin dependent diabetes.
    Shah PK; Lakhotia M; Purohit A; Jain SK; Gupta SK; Bhandari P
    J Assoc Physicians India; 1993 Nov; 41(11):703-5. PubMed ID: 8005921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes.
    Pistrosch F; Schaper F; Passauer J; Koehler C; Bornstein SR; Hanefeld M
    Horm Metab Res; 2009 Feb; 41(2):104-8. PubMed ID: 19061152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Short term assessment of anthropometric indices and metabolic parameters in obese subjects treated with acarbose].
    Coli P; Pea E; Lacorte M; Passaglia C; Carrai M
    Minerva Med; 1996 Apr; 87(4):161-70. PubMed ID: 8700340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
    Fölsch UR; Lembcke B
    Internist (Berl); 1991 Dec; 32(12):699-707. PubMed ID: 1823561
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acarbose in the treatment of non-insulin-dependent diabetes mellitus; a new principle].
    Drent ML; van der Veen EA
    Ned Tijdschr Geneeskd; 1992 Feb; 136(7):308-10. PubMed ID: 1538796
    [No Abstract]   [Full Text] [Related]  

  • 33. [alpha-Glucosidase inhibitors in the therapy of diabetes mellitus].
    Giorgino R; Damato A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():61S-65S. PubMed ID: 8562269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
    Chiasson JL
    Diabet Med; 1996; 13(3 Suppl 2):S23-4. PubMed ID: 8689858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoothing effect of a new alpha-glucosidase inhibitor BAY m 1099 on blood glucose profiles of sulfonylurea-treated type II diabetic patients.
    Arends J; Willms BH
    Horm Metab Res; 1986 Nov; 18(11):761-4. PubMed ID: 3539737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New, in Austria registered specialty drugs. Glucobay (acarbose)].
    Sturm M
    Wien Klin Wochenschr; 1992; 104(11):329-36. PubMed ID: 1621396
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozotocin-induced diabetic rats.
    Yamashita K; Sugawara S; Sakairi I
    Horm Metab Res; 1984 Apr; 16(4):179-82. PubMed ID: 6373545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
    Madar Z; Melamed EC; Zimlichman R
    Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
    Schwartzkopff W; Calder D
    Med Welt; 1984 Feb; 35(6):169-74. PubMed ID: 6369065
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acarbose, an unduly neglected antidiabetic drug].
    Iványi J; Gyimesi A
    Orv Hetil; 1996 Dec; 137(49):2737-41. PubMed ID: 9679608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.